Management of COVID-19 associated coagulopathy in critically ill patients and the risk of acquired von willebrand syndrome

Hiroyasu Ishikura; Yuhei Irie; Maiko Nakashio; Junichi Maruyama; Yoshihiko Nakamura; Takahiro Yamagaito; Maho Yoshida; Hiroki Hatomoto; Shintaro Yamasaki; Kota Hoshino

doi:10.1038/s41598-025-99786-z

Management of COVID-19 associated coagulopathy in critically ill patients and the risk of acquired von willebrand syndrome

H Hiroyasu Ishikura Y Yuhei Irie M Maiko Nakashio J Junichi Maruyama Y Yoshihiko Nakamura T Takahiro Yamagaito M Maho Yoshida H Hiroki Hatomoto S Shintaro Yamasaki K Kota Hoshino

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Scientific Reports

Volume / Issue Vol. 15, Issue 1

Published June 02, 2025

DOI 10.1038/s41598-025-99786-z

ISSN 2045-2322

Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (10)

H

Hiroyasu Ishikura

Y

Yuhei Irie

M

Maiko Nakashio

J

Junichi Maruyama

Y

Yoshihiko Nakamura

T

Takahiro Yamagaito

M

Maho Yoshida

H

Hiroki Hatomoto

S

Shintaro Yamasaki

K

Kota Hoshino

Management of COVID-19 associated coagulopathy in critically ill patients and the risk of acquired von willebrand syndrome

Article Details

Journal Info

Authors (10)

Related Articles from this Journal

AI models of unstable flow exhibit hallucination

The MCAA-YOLO + XPBI integrated model provides a hybrid intelligent measurement method for predicting the body weight of Hu sheep

Application of iron nano-biofertilizers as a sustainable approach to enhance growth and micronutrient uptake in soybean

Adolescents’ status-dependent public and private conformity to prosocial and antisocial decisions in a public goods game

An explainable hierarchical capsule network framework for supporting expert sensory evaluation of herbal medicines with natural language generation